FDA 483 - Allay Pharmaceuticals, LLC - November 15, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Allay Pharmaceuticals, LLC in Miami Gardens, FL, a drug manufacturer, revealed significant deficiencies in their quality control unit procedures and master production records. The firm's written procedures for complaint handling, adverse event reporting, and raw material sampling were found to be incomplete, contain inapplicable requirements, or not be fully followed. Additionally, master batch records for NP Thyroid tablets lacked complete manufacturing and sampling instructions.
ID · 94cd1a5a-c25d-4a99-979f-66078c50817b